As of November 2024, Human Stem Cells Institute has a market cap of $68.87M. This makes Human Stem Cells Institute the world's 23369th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $96.08M | 2.80% |
2023 | $93.46M | 64.36% |
2022 | $56.86M | -45.99% |
2021 | $105.28M | 201.10% |
2020 | $34.97M | 193.76% |
2019 | $11.90M | 64.64% |
2018 | $7.23M | -31.39% |
2017 | $10.54M | -36.29% |
2016 | $16.54M | 72.73% |
2015 | $9.58M | -8.73% |
2014 | $10.49M | -41.16% |
2013 | $17.83M | 43.19% |
2012 | $12.45M | 36.72% |
2011 | $9.11M | -22.77% |
2010 | $11.79M | -29.86% |
2009 | $16.81M | - |